Cantor Fitzgerald analyst Louise Chen initiated coverage of Zai Lab with an Overweight rating and $70 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ZLAB:
- Zai Lab Announces Second Quarter 2023 Financial Results and Corporate Updates
- Zai Lab reports Q2 EPS (13c), consensus (79c)
- ZLAB Earnings this Week: How Will it Perform?
- Zai Lab to Announce Second Quarter 2023 Financial Results and Corporate Updates on August 7, 2023
- JAMA Oncology Publishes Data from Zai Lab Study Demonstrating Significant Reduction in Disease Progression or Death with ZEJULA (Niraparib) Maintenance Therapy in Broad Population of Advanced Ovarian Cancer Patients